Skip to main content
 

Preventric Diagnostics

Preventric Diagnostics

Preventric is a commercial-stage digital health company redefining the way vascular diseases are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities. The company derives its revenue in the United States, and its BPro wearable is an FDA cleared Type II medical device, with nine patents.

Preventric is taking a leading & disruptive role in the future of vascular health management, which affects 100 million Americans.

More News

  • Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HF

  • AHA Innovators’ Network Member Accurkardia receives FDA Breakthrough Device Designation on New Condition Area

  • Target: BP™ initiative helps more than 9M Americans with hypertension